Stage III Grade 3 Follicular Lymphoma Completed Phase 1 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028630 (Stage III Grade 3 Follicular Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00343798A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesTreatment